The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Axsome Therapeutics, Inc(NASDAQ:AXSM) 
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in t...
Website: http://www.axsome.com
Founded: 2012
Full Time Employees: 53
Sector: Healthcare
Industry: Biotechnology
Axsome Therapeutics Days Payable Outstanding ttm (DPO)
Axsome Therapeutics Days Receivable Outstanding ttm (DSO)
Axsome Therapeutics Days Inventory Outstanding ttm (DIO)
Axsome Therapeutics Op Cashflow Per Share ttm
Axsome Therapeutics Free Cashflow Per Share ttm
Axsome Therapeutics Cash Per Share ttm
Axsome Therapeutics P/S ratio ttm
Axsome Therapeutics (GAAP) P/E ratio ttm
Axsome Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.